Navigation Links
PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference
Date:12/1/2009

BOSTON, Dec. 1 /PRNewswire-FirstCall/ -- An expert from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will lead a panel discussion on innovative approaches to drug development in Asia at the Partnerships in Clinical Trials Asia Pacific Conference, being held December 1-3, 2009 at the Intercontinental Hotel in Singapore. PAREXEL is a sponsor of the conference, which is focused on maximizing efficiency and maintaining quality of clinical trials in the Asia/Pacific region, as well as sharing successful strategies for introducing new products into this growth market.

During the panel session, "Asia's Pharma Industry - Innovative Drug Development," taking place on Wednesday, December 2 at 10:00 a.m., Edmund Leong, Director, Clinical Research Services, Asia/Pacific, PAREXEL will moderate a discussion featuring industry experts from Allergan, a multi-specialty health care company, and CK Life Sciences, which is engaged in the business of research and development, commercialization, marketing and sale of biotechnology products. The panelists will offer insights and experiences for successfully managing drug development in the Asia/Pacific region.

With 15 locations throughout the Asia/Pacific region, including Singapore, PAREXEL has had a long-term commitment to providing a high level of standardization and quality clinical development services in these geographies. PAREXEL helps clients address key challenges in conducting studies in the Asia/Pacific region and globally, including accessing diverse patient populations, navigating regulatory issues, identifying investigators, and ensuring data quality.

Co
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument
2. PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results
3. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
4. PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
5. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
6. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
9. Malaria Experts Call on Federal Government to Increase Support for Research and Development
10. Panel of Osteoarthritis Experts Develops Optimal Profile of Exogenous Hyaluronic Acid
11. SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... shares have been approved for listing and trading on the ... ESSA will begin trading on NASDAQ on July 9, 2015.  ... Exchange under the symbol "EPI". As a result ... each of the Company,s outstanding special warrants issued on January ...
(Date:7/2/2015)... , July 2, 2015  Before you head outdoors ... so you can stay safe and healthy. Take steps to ... Infographic http://nyackhospital.org/summersafety Protect Your Skin From ... the sun can increase your risk of skin cancer. To ... as much as possible, especially during midday hours. Wear a ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has ... Analog, Application, End-User & by Region - Global Trends & ... This market is projected to reach about $2.5 Million by ... and rising opportunities in countries such as India ... , and Brazil . In 2013, ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... 21, 2007 - Antigenics Inc.,(NASDAQ: AGEN) today ... 3 investigational therapeutic cancer vaccine,Oncophage(R) (vitespen). The ... data collection, showed that in a substantial,subset ... risk for disease,recurrence, Oncophage demonstrated a clinically ...
... FDA for long-term,maintenance treatment of COPD bronchoconstriction; ... lung function,comparable to dry powder formoterol, enhanced ... -- , NAPA, CA (May 20, 2007) ... the American Thoracic Society (ATS),demonstrate that Perforomist™ ...
Cached Medicine Technology:Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
(Date:7/3/2015)... ... ... Food Bank will hopefully be getting a large donation of canned food items at ... SC are making it their mission to collect as many canned items as possible. Donations ... the public as well. As part of the canned food drive, these local chiropractors will ...
(Date:7/3/2015)... ... , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod ... . To be held from March 4th - 6th, the 2016 (a previous announcement ... Dallas. , Designed to take participants from the basic training and fundamentals of nasal ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Talcum powder ... to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the previous ... powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. The ...
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness ... where they provide members of the Red Deer community with free fitness training and ... fitness training, games, food, events and entertainment raised thousands of charity dollars and ended ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on ... American society right now," Becic said. "We must understand the magnitude of this discovery. ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... Researchers at Washington University School of Medicine in St. ... the National Cancer Institute (NCI) to study the relationship ... fund the Transdisciplinary Research on Energetics and Cancer (TREC) ... diet, weight, physical activity and the environment on cancer ...
... Joint Research Centre has developed three new methods to ... in sports drinks imported from Taiwan. In ... that significant amounts of phthalates were illegally added to ... to affect reproductive performance and fertility, and have been ...
... HealthDay Reporter , THURSDAY, July 28 (HealthDay News) ... years after a breast cancer diagnosis were nearly 40 percent ... lasted for more than a decade after they stopped taking ... results of about 20 randomized controlled trials on a five-year ...
... New research focusing on high-frequency oscillations, termed ripples ... may provide an important marker for the localization ... According to the study now available in ... Against Epilepsy (ILAE), the resection of brain regions ...
... HealthDay Reporter , THURSDAY, July 28 (HealthDay News) -- ... it,s also a time when high temperatures can take a ... for Disease Control and Prevention (CDC) say that from 2001 ... rooms for heat-related illness caused while playing sports or engaged ...
... HealthDay Reporter , THURSDAY, July 28 (HealthDay News) -- ... to pick up speed so that the nation will shell out ... And an increasing amount of that bill -- almost half ... care spending dipped to a "historic low" of 3.9 percent in ...
Cached Medicine News:Health News:WU studies obesity, cancer link with $9.2 million grant 2Health News:JRC develops new testing methods for contaminated sports drinks from Taiwan 2Health News:Tamoxifen Wards Off Breast Cancer's Return for More Than a Decade 2Health News:Tamoxifen Wards Off Breast Cancer's Return for More Than a Decade 3Health News:Fast ripples confirmed to be valuable biomarker of area responsible for seizure activity in children 2Health News:Heat-Linked Illnesses Strike Thousands Each Year: Report 2Health News:Heat-Linked Illnesses Strike Thousands Each Year: Report 3Health News:U.S. to Pay Bigger Share of Rising Cost of Health Care 2Health News:U.S. to Pay Bigger Share of Rising Cost of Health Care 3
For the measurement of vaginal pH as part of a self examination programme to help reduce the risk of pre-term birth...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: